NOBORI Biolimus A9-Eluting Stent

Biolimus A9-eluting stent · Terumo Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NOBORI Biolimus A9-Eluting Stent, covering 2013-11-06 to 2013-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Everolimus-eluting(PROMUS-ELEMENT) vs. Biolimus A9-Eluting(NOBORI) Stents for Long-Coronary Lesions [Phase 4]